首页> 外文OA文献 >SAT0229 Rheumatoid arthritis treatment with combination of three conventional synthetic disease modifying anti-rheumatic drugs (CSDMARDS) and its effectiveness on disease control in a short term compared to biologic dmards treatment after propensity score matching procedure implemented

【2h】

SAT0229 Rheumatoid arthritis treatment with combination of three conventional synthetic disease modifying anti-rheumatic drugs (CSDMARDS) and its effectiveness on disease control in a short term compared to biologic dmards treatment after propensity score matching procedure implemented

机译：SAT0229随着在倾销得分匹配程序后，三种常规合成疾病改性抗风湿药物（CSDMARDS）的组合治疗三种常规合成疾病的组合及其对短期内的疾病控制的有效性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
I. Yoshii; T. Chijiwa;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of biologics compared to conventional disease-modifying anti-rheumatic drugs (cDMARDs) for treatment of rheumatoid arthritis (RA): a register study [J] . Joensuu J. T., Aaltonen K. J., Aronen P., Scandinavian journal of rheumatology . 2015,第6期

机译：与传统的疾病缓解类抗风湿药（cDMARDs）相比，生物制剂治疗类风湿关节炎（RA）的成本效益：一项注册研究
2. Longitudinal Changes in Relative Market Share Proportions of Biologic, and Targeted Synthetic, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for Treatment of Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (OBRI) [J] . Hepworth Elliot, Movahedi Mohammad, Rampakakis Emmanouil, The Journal of rheumatology . 2019,第7期

机译：相对市场份额的纵向变化，生物学，靶向合成，疾病改性抗风湿药物（DMARDs）用于治疗类风湿性关节炎：由安大略省最佳实践研究倡议（OBRI）的结果
3. Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study [J] . Joensuu Jaana T., Aaltonen Kalle J., Aronen Pasi, Rheumatology . 2016,第10期

机译：登记研究研究了生物制剂与传统的合成疾病抗风湿药相比在类风湿关节炎中的成本效益
4. Comparing short-term outcomes of three problem gambling treatments: A multi-group propensity score analysis. [D] . Soberay, Adam D. 2015

机译：比较三种问题赌博疗法的短期结果：多组倾向得分分析。
5. Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison [O] . B Fautrel, B Zhu, P C Taylor, 2020

机译：对幼稚性关节炎患者的痛苦痛和毒素和Tofacitinib的痛苦和物理功能改善的比较有效性与生物学或常规的合成疾病改性抗胃酸药物治疗的类风湿性关节炎患者：匹配调整后的间接比较
6. FRI0077 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER IN RHEUMATOID ARTHRITIS PATIENTS [O] . Robin K Dore, Jenya Antonova, Huang Huan, 2019

机译：Fri0077在随后成为类风湿性关节炎患者的CSDARD响应不足之前和之后，Fri0077常规合成疾病改性抗风湿药物（CSDMARDS）的持续时间短

SAT0229 Rheumatoid arthritis treatment with combination of three conventional synthetic disease modifying anti-rheumatic drugs (CSDMARDS) and its effectiveness on disease control in a short term compared to biologic dmards treatment after propensity score matching procedure implemented

著录项

引文网络

相似文献

相关主题

期刊订阅